speb/financial-data huggingface dataset:
EMR cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Investing Activities: -5684000000.00
EMR cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Operating Activities: 2048000000.00
EMR cash_flow (annual, 2022-09-30) — Cash From Discontinued Investing Activities: 350000000.00
EMR cash_flow (annual, 2022-09-30) — Cash From Discontinued Operating Activities: 874000000.00
EMR cash_flow (annual, 2022-09-30) — Change In Account Payable: 147000000.00
EMR cash_flow (annual, 2022-09-30) — Change In Accrued Expense: 74000000.00
EMR cash_flow (annual, 2022-09-30) — Change In Inventory: -334000000.00
EMR cash_flow (annual, 2022-09-30) — Change In Other Current Assets: -56000000.00
EMR cash_flow (annual, 2022-09-30) — Change In Payable: 147000000.00
EMR cash_flow (annual, 2022-09-30) — Change In Payables And Accrued Expense: 221000000.00
EMR cash_flow (annual, 2022-09-30) — Change In Receivables: -143000000.00
EMR cash_flow (annual, 2022-09-30) — Change In Working Capital: -312000000.00
EMR cash_flow (annual, 2022-09-30) — Changes In Cash: -364000000.00
EMR balance_sheet (annual, 2022-09-30) — Commercial Paper: 1599000000.00
EMR balance_sheet (annual, 2022-09-30) — Common Stock: 477000000.00
EMR cash_flow (annual, 2022-09-30) — Common Stock Dividend Paid: -1223000000.00
EMR balance_sheet (annual, 2022-09-30) — Common Stock Equity: 10364000000.00
EMR cash_flow (annual, 2022-09-30) — Common Stock Payments: -500000000.00
EMR balance_sheet (annual, 2022-09-30) — Construction In Progress: 390000000.00
EMR income_statement (annual, 2022-09-30) — Cost Of Revenue: 7498000000.00
EMR balance_sheet (annual, 2022-09-30) — Current Accrued Expenses: 3038000000.00
EMR balance_sheet (annual, 2022-09-30) — Current Assets: 8506000000.00
EMR balance_sheet (annual, 2022-09-30) — Current Debt: 2115000000.00
EMR balance_sheet (annual, 2022-09-30) — Current Debt And Capital Lease Obligation: 2115000000.00
EMR balance_sheet (annual, 2022-09-30) — Current Liabilities: 7777000000.00
EMR cash_flow (annual, 2022-09-30) — Depreciation: 312000000.00
EMR cash_flow (annual, 2022-09-30) — Depreciation Amortization Depletion: 842000000.00
EMR income_statement (annual, 2022-09-30) — Depreciation Amortization Depletion Income Statement: 336000000.00
EMR cash_flow (annual, 2022-09-30) — Depreciation And Amortization: 842000000.00
EMR income_statement (annual, 2022-09-30) — Depreciation And Amortization In Income Statement: 336000000.00
EMR income_statement (annual, 2022-09-30) — Diluted Average Shares: 596300000.00
EMR income_statement (annual, 2022-09-30) — Diluted EPS: 5.41
EMR income_statement (annual, 2022-09-30) — Diluted NI Availto Com Stockholders: 3231000000.00
EMR income_statement (annual, 2022-09-30) — EBIT: 2660000000.00
EMR income_statement (annual, 2022-09-30) — EBITDA: 3502000000.00
EMR income_statement (annual, 2022-09-30) — Earnings From Equity Interest: 453000000.00
EMR cash_flow (annual, 2022-09-30) — Effect Of Exchange Rate Changes: -186000000.00
EMR balance_sheet (annual, 2022-09-30) — Employee Benefits: 427000000.00
EMR cash_flow (annual, 2022-09-30) — End Cash Position: 1804000000.00
EMR cash_flow (annual, 2022-09-30) — Financing Cash Flow: 2048000000.00
EMR balance_sheet (annual, 2022-09-30) — Finished Goods: 417000000.00
EMR cash_flow (annual, 2022-09-30) — Free Cash Flow: 2623000000.00
EMR cash_flow (annual, 2022-09-30) — Gain Loss On Investment Securities: -453000000.00
EMR cash_flow (annual, 2022-09-30) — Gain Loss On Sale Of Business: -939000000.00
EMR income_statement (annual, 2022-09-30) — Gain On Sale Of Business: -135000000.00
EMR income_statement (annual, 2022-09-30) — Gain On Sale Of Security: 18000000.00
EMR balance_sheet (annual, 2022-09-30) — Gains Losses Not Affecting Retained Earnings: -1485000000.00
EMR income_statement (annual, 2022-09-30) — General And Administrative Expense: 3614000000.00
EMR balance_sheet (annual, 2022-09-30) — Goodwill: 13946000000.00
EMR balance_sheet (annual, 2022-09-30) — Goodwill And Other Intangible Assets: 20518000000.00
EMR balance_sheet (annual, 2022-09-30) — Gross Accounts Receivable: 2361000000.00
EMR balance_sheet (annual, 2022-09-30) — Gross PPE: 5390000000.00
EMR income_statement (annual, 2022-09-30) — Gross Profit: 6306000000.00
EMR income_statement (annual, 2022-09-30) — Interest Expense: 228000000.00
EMR income_statement (annual, 2022-09-30) — Interest Expense Non Operating: 228000000.00
EMR income_statement (annual, 2022-09-30) — Interest Income: 34000000.00
EMR income_statement (annual, 2022-09-30) — Interest Income Non Operating: 34000000.00
EMR balance_sheet (annual, 2022-09-30) — Inventory: 1742000000.00
EMR balance_sheet (annual, 2022-09-30) — Invested Capital: 20738000000.00
EMR cash_flow (annual, 2022-09-30) — Investing Cash Flow: -5334000000.00
EMR balance_sheet (annual, 2022-09-30) — Investments And Advances: 0.00
EMR cash_flow (annual, 2022-09-30) — Issuance Of Debt: 5378000000.00
EMR balance_sheet (annual, 2022-09-30) — Land And Improvements: 200000000.00
EMR balance_sheet (annual, 2022-09-30) — Liabilities Heldfor Sale Non Current: 167000000.00
EMR balance_sheet (annual, 2022-09-30) — Long Term Capital Lease Obligation: 312000000.00
EMR balance_sheet (annual, 2022-09-30) — Long Term Debt: 8259000000.00
EMR balance_sheet (annual, 2022-09-30) — Long Term Debt And Capital Lease Obligation: 8571000000.00
EMR cash_flow (annual, 2022-09-30) — Long Term Debt Issuance: 2975000000.00
EMR cash_flow (annual, 2022-09-30) — Long Term Debt Payments: -522000000.00
EMR balance_sheet (annual, 2022-09-30) — Long Term Equity Investment: 0.00
EMR balance_sheet (annual, 2022-09-30) — Machinery Furniture Equipment: 3300000000.00
EMR balance_sheet (annual, 2022-09-30) — Minority Interest: 5952000000.00
EMR income_statement (annual, 2022-09-30) — Minority Interests: 1000000.00
EMR cash_flow (annual, 2022-09-30) — Net Business Purchase And Sale: -5685000000.00
EMR cash_flow (annual, 2022-09-30) — Net Common Stock Issuance: -500000000.00
EMR balance_sheet (annual, 2022-09-30) — Net Debt: 8570000000.00
EMR income_statement (annual, 2022-09-30) — Net Income: 3231000000.00
EMR income_statement (annual, 2022-09-30) — Net Income Common Stockholders: 3231000000.00
EMR income_statement (annual, 2022-09-30) — Net Income Continuous Operations: 1883000000.00
EMR income_statement (annual, 2022-09-30) — Net Income Discontinuous Operations: 1347000000.00
EMR income_statement (annual, 2022-09-30) — Net Income From Continuing And Discontinued Operation: 3231000000.00
EMR income_statement (annual, 2022-09-30) — Net Income From Continuing Operation Net Minority Interest: 1884000000.00
EMR cash_flow (annual, 2022-09-30) — Net Income From Continuing Operations: 1883000000.00
EMR income_statement (annual, 2022-09-30) — Net Income Including Noncontrolling Interests: 3230000000.00
EMR income_statement (annual, 2022-09-30) — Net Interest Income: -194000000.00
EMR cash_flow (annual, 2022-09-30) — Net Investment Purchase And Sale: 438000000.00
EMR cash_flow (annual, 2022-09-30) — Net Issuance Payments Of Debt: 3691000000.00
EMR cash_flow (annual, 2022-09-30) — Net Long Term Debt Issuance: 2453000000.00
EMR income_statement (annual, 2022-09-30) — Net Non Operating Interest Income Expense: -194000000.00
EMR cash_flow (annual, 2022-09-30) — Net Other Financing Charges: 80000000.00
EMR cash_flow (annual, 2022-09-30) — Net Other Investing Changes: -138000000.00
EMR balance_sheet (annual, 2022-09-30) — Net PPE: 2239000000.00
EMR cash_flow (annual, 2022-09-30) — Net Short Term Debt Issuance: 1238000000.00
EMR balance_sheet (annual, 2022-09-30) — Net Tangible Assets: -10154000000.00
EMR balance_sheet (annual, 2022-09-30) — Non Current Deferred Liabilities: 1714000000.00
EMR balance_sheet (annual, 2022-09-30) — Non Current Deferred Taxes Liabilities: 1714000000.00
EMR balance_sheet (annual, 2022-09-30) — Non Current Note Receivables: 0.00
EMR balance_sheet (annual, 2022-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 427000000.00
EMR income_statement (annual, 2022-09-30) — Normalized EBITDA: 3785000000.00
EMR income_statement (annual, 2022-09-30) — Normalized Income: 2103042000.00
EMR cash_flow (annual, 2022-09-30) — Operating Cash Flow: 2922000000.00
EMR cash_flow (annual, 2022-09-30) — Operating Gains Losses: -494000000.00
EMR income_statement (annual, 2022-09-30) — Operating Income: 2356000000.00
EMR income_statement (annual, 2022-09-30) — Operating Revenue: 13804000000.00
EMR balance_sheet (annual, 2022-09-30) — Ordinary Shares Number: 591400000.00
EMR balance_sheet (annual, 2022-09-30) — Other Current Assets: 1301000000.00
EMR balance_sheet (annual, 2022-09-30) — Other Current Borrowings: 516000000.00
EMR balance_sheet (annual, 2022-09-30) — Other Current Liabilities: 1348000000.00
EMR balance_sheet (annual, 2022-09-30) — Other Equity Adjustments: -1485000000.00
EMR income_statement (annual, 2022-09-30) — Other Gand A: 3614000000.00
EMR income_statement (annual, 2022-09-30) — Other Income Expense: 270000000.00
EMR balance_sheet (annual, 2022-09-30) — Other Intangible Assets: 6572000000.00
EMR cash_flow (annual, 2022-09-30) — Other Non Cash Items: 4000000.00
EMR balance_sheet (annual, 2022-09-30) — Other Non Current Assets: 4409000000.00
EMR balance_sheet (annual, 2022-09-30) — Other Non Current Liabilities: 700000000.00
EMR income_statement (annual, 2022-09-30) — Other Non Operating Income Expenses: 100000000.00
EMR balance_sheet (annual, 2022-09-30) — Payables: 1276000000.00
EMR balance_sheet (annual, 2022-09-30) — Payables And Accrued Expenses: 4314000000.00
EMR cash_flow (annual, 2022-09-30) — Pension And Employee Benefit Expense: -41000000.00
EMR income_statement (annual, 2022-09-30) — Pretax Income: 2432000000.00
EMR balance_sheet (annual, 2022-09-30) — Properties: 0.00
EMR cash_flow (annual, 2022-09-30) — Purchase Of Business: -5702000000.00
EMR balance_sheet (annual, 2022-09-30) — Raw Materials: 1325000000.00
EMR balance_sheet (annual, 2022-09-30) — Receivables: 2261000000.00
EMR income_statement (annual, 2022-09-30) — Reconciled Cost Of Revenue: 6992000000.00
EMR income_statement (annual, 2022-09-30) — Reconciled Depreciation: 842000000.00
EMR cash_flow (annual, 2022-09-30) — Repayment Of Debt: -1687000000.00
EMR cash_flow (annual, 2022-09-30) — Repurchase Of Capital Stock: -500000000.00
EMR income_statement (annual, 2022-09-30) — Restructuring And Mergern Acquisition: 166000000.00
EMR balance_sheet (annual, 2022-09-30) — Retained Earnings: 28053000000.00
EMR cash_flow (annual, 2022-09-30) — Sale Of Business: 17000000.00
EMR cash_flow (annual, 2022-09-30) — Sale Of Investment: 438000000.00
EMR income_statement (annual, 2022-09-30) — Selling General And Administration: 3614000000.00
EMR balance_sheet (annual, 2022-09-30) — Share Issued: 953400000.00
EMR cash_flow (annual, 2022-09-30) — Short Term Debt Issuance: 2403000000.00
EMR cash_flow (annual, 2022-09-30) — Short Term Debt Payments: -1165000000.00
EMR income_statement (annual, 2022-09-30) — Special Income Charges: -301000000.00
EMR cash_flow (annual, 2022-09-30) — Stock Based Compensation: 125000000.00
EMR balance_sheet (annual, 2022-09-30) — Stockholders Equity: 10364000000.00
EMR balance_sheet (annual, 2022-09-30) — Tangible Book Value: -10154000000.00
EMR income_statement (annual, 2022-09-30) — Tax Effect Of Unusual Items: -63958000.00
EMR income_statement (annual, 2022-09-30) — Tax Provision: 549000000.00
EMR income_statement (annual, 2022-09-30) — Tax Rate For Calcs: 0.23
EMR balance_sheet (annual, 2022-09-30) — Total Assets: 35672000000.00
EMR balance_sheet (annual, 2022-09-30) — Total Capitalization: 18623000000.00
EMR balance_sheet (annual, 2022-09-30) — Total Debt: 10686000000.00
EMR balance_sheet (annual, 2022-09-30) — Total Equity Gross Minority Interest: 16316000000.00
EMR income_statement (annual, 2022-09-30) — Total Expenses: 11448000000.00
EMR balance_sheet (annual, 2022-09-30) — Total Liabilities Net Minority Interest: 19356000000.00
EMR balance_sheet (annual, 2022-09-30) — Total Non Current Assets: 27166000000.00
EMR balance_sheet (annual, 2022-09-30) — Total Non Current Liabilities Net Minority Interest: 11579000000.00
EMR income_statement (annual, 2022-09-30) — Total Unusual Items: -283000000.00
EMR income_statement (annual, 2022-09-30) — Total Unusual Items Excluding Goodwill: -283000000.00
EMR balance_sheet (annual, 2022-09-30) — Treasury Shares Number: 362000000.00
EMR balance_sheet (annual, 2022-09-30) — Treasury Stock: 16738000000.00
EMR balance_sheet (annual, 2022-09-30) — Working Capital: 729000000.00
EMR income_statement (annual, 2023-09-30) — +Operating Expense: 4668000000.00
EMR income_statement (annual, 2023-09-30) — +Total Revenue: 15165000000.00
EMR balance_sheet (annual, 2023-09-30) — Accounts Payable: 1275000000.00
EMR balance_sheet (annual, 2023-09-30) — Accounts Receivable: 2518000000.00
EMR balance_sheet (annual, 2023-09-30) — Accumulated Depreciation: -3161000000.00
EMR balance_sheet (annual, 2023-09-30) — Additional Paid In Capital: 62000000.00
EMR balance_sheet (annual, 2023-09-30) — Allowance For Doubtful Accounts Receivable: -100000000.00
EMR income_statement (annual, 2023-09-30) — Amortization: 482000000.00
EMR cash_flow (annual, 2023-09-30) — Amortization Cash Flow: 764000000.00
EMR cash_flow (annual, 2023-09-30) — Amortization Of Intangibles: 764000000.00
EMR income_statement (annual, 2023-09-30) — Amortization Of Intangibles Income Statement: 482000000.00
EMR cash_flow (annual, 2023-09-30) — Asset Impairment Charge: 0.00
EMR balance_sheet (annual, 2023-09-30) — Assets Held For Sale Current: 0.00
EMR income_statement (annual, 2023-09-30) — Basic Average Shares: 572000000.00
EMR income_statement (annual, 2023-09-30) — Basic EPS: 23.11
EMR cash_flow (annual, 2023-09-30) — Beginning Cash Position: 1804000000.00
EMR balance_sheet (annual, 2023-09-30) — Buildings And Improvements: 1758000000.00
EMR cash_flow (annual, 2023-09-30) — Capital Expenditure: -363000000.00
EMR cash_flow (annual, 2023-09-30) — Capital Expenditure Reported: -363000000.00
EMR balance_sheet (annual, 2023-09-30) — Capital Lease Obligations: 404000000.00
EMR balance_sheet (annual, 2023-09-30) — Capital Stock: 477000000.00
EMR balance_sheet (annual, 2023-09-30) — Cash And Cash Equivalents: 8051000000.00
EMR balance_sheet (annual, 2023-09-30) — Cash Cash Equivalents And Short Term Investments: 8051000000.00
EMR cash_flow (annual, 2023-09-30) — Cash Dividends Paid: -1198000000.00
EMR cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Financing Activities: -6823000000.00
EMR cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Investing Activities: -115000000.00
EMR cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Operating Activities: 2710000000.00
EMR cash_flow (annual, 2023-09-30) — Cash From Discontinued Investing Activities: 12530000000.00
EMR cash_flow (annual, 2023-09-30) — Cash From Discontinued Operating Activities: -2073000000.00
EMR cash_flow (annual, 2023-09-30) — Change In Account Payable: -17000000.00
EMR cash_flow (annual, 2023-09-30) — Change In Accrued Expense: 221000000.00
EMR cash_flow (annual, 2023-09-30) — Change In Inventory: -160000000.00
EMR cash_flow (annual, 2023-09-30) — Change In Other Current Assets: -1000000.00
EMR cash_flow (annual, 2023-09-30) — Change In Payable: -17000000.00
EMR cash_flow (annual, 2023-09-30) — Change In Payables And Accrued Expense: 204000000.00
EMR cash_flow (annual, 2023-09-30) — Change In Receivables: -191000000.00
EMR cash_flow (annual, 2023-09-30) — Change In Working Capital: -148000000.00
EMR cash_flow (annual, 2023-09-30) — Changes In Cash: 6229000000.00
EMR balance_sheet (annual, 2023-09-30) — Commercial Paper: 1000000.00
EMR balance_sheet (annual, 2023-09-30) — Common Stock: 477000000.00
EMR cash_flow (annual, 2023-09-30) — Common Stock Dividend Paid: -1198000000.00
EMR balance_sheet (annual, 2023-09-30) — Common Stock Equity: 20689000000.00
EMR cash_flow (annual, 2023-09-30) — Common Stock Payments: -2214000000.00
EMR balance_sheet (annual, 2023-09-30) — Construction In Progress: 283000000.00
EMR income_statement (annual, 2023-09-30) — Cost Of Revenue: 7738000000.00
EMR balance_sheet (annual, 2023-09-30) — Current Accrued Expenses: 3210000000.00
EMR balance_sheet (annual, 2023-09-30) — Current Assets: 13819000000.00
EMR balance_sheet (annual, 2023-09-30) — Current Debt: 547000000.00
EMR balance_sheet (annual, 2023-09-30) — Current Debt And Capital Lease Obligation: 547000000.00
EMR balance_sheet (annual, 2023-09-30) — Current Liabilities: 5032000000.00
EMR cash_flow (annual, 2023-09-30) — Depreciation: 287000000.00
EMR cash_flow (annual, 2023-09-30) — Depreciation Amortization Depletion: 1051000000.00
EMR income_statement (annual, 2023-09-30) — Depreciation Amortization Depletion Income Statement: 482000000.00
EMR cash_flow (annual, 2023-09-30) — Depreciation And Amortization: 1051000000.00
EMR income_statement (annual, 2023-09-30) — Depreciation And Amortization In Income Statement: 482000000.00
EMR income_statement (annual, 2023-09-30) — Diluted Average Shares: 577300000.00
EMR income_statement (annual, 2023-09-30) — Diluted EPS: 22.88
EMR income_statement (annual, 2023-09-30) — Diluted NI Availto Com Stockholders: 13219000000.00
EMR income_statement (annual, 2023-09-30) — EBIT: 3164000000.00
EMR income_statement (annual, 2023-09-30) — EBITDA: 4215000000.00
EMR income_statement (annual, 2023-09-30) — Earnings From Equity Interest: 161000000.00
EMR cash_flow (annual, 2023-09-30) — Effect Of Exchange Rate Changes: 18000000.00
EMR balance_sheet (annual, 2023-09-30) — Employee Benefits: 435000000.00
EMR cash_flow (annual, 2023-09-30) — End Cash Position: 8051000000.00
EMR cash_flow (annual, 2023-09-30) — Financing Cash Flow: -6823000000.00
EMR balance_sheet (annual, 2023-09-30) — Finished Goods: 446000000.00
EMR cash_flow (annual, 2023-09-30) — Free Cash Flow: 274000000.00
EMR cash_flow (annual, 2023-09-30) — Gain Loss On Investment Securities: -161000000.00
EMR income_statement (annual, 2023-09-30) — Gain On Sale Of Business: -47000000.00
EMR income_statement (annual, 2023-09-30) — Gain On Sale Of Security: 19000000.00
EMR balance_sheet (annual, 2023-09-30) — Gains Losses Not Affecting Retained Earnings: -1253000000.00
EMR income_statement (annual, 2023-09-30) — General And Administrative Expense: 4186000000.00
EMR balance_sheet (annual, 2023-09-30) — Goodwill: 14480000000.00
EMR balance_sheet (annual, 2023-09-30) — Goodwill And Other Intangible Assets: 20743000000.00
EMR balance_sheet (annual, 2023-09-30) — Gross Accounts Receivable: 2618000000.00
EMR balance_sheet (annual, 2023-09-30) — Gross PPE: 5524000000.00
EMR income_statement (annual, 2023-09-30) — Gross Profit: 7427000000.00
EMR income_statement (annual, 2023-09-30) — Interest Expense: 261000000.00
EMR income_statement (annual, 2023-09-30) — Interest Expense Non Operating: 261000000.00
EMR income_statement (annual, 2023-09-30) — Interest Income: 268000000.00
EMR income_statement (annual, 2023-09-30) — Interest Income Non Operating: 268000000.00
EMR balance_sheet (annual, 2023-09-30) — Inventory: 2006000000.00
EMR balance_sheet (annual, 2023-09-30) — Invested Capital: 28846000000.00
EMR cash_flow (annual, 2023-09-30) — Investing Cash Flow: 12415000000.00
EMR balance_sheet (annual, 2023-09-30) — Investments And Advances: 3255000000.00
EMR cash_flow (annual, 2023-09-30) — Issuance Of Debt: 395000000.00
EMR balance_sheet (annual, 2023-09-30) — Land And Improvements: 255000000.00
EMR balance_sheet (annual, 2023-09-30) — Liabilities Heldfor Sale Non Current: 0.00
EMR balance_sheet (annual, 2023-09-30) — Long Term Capital Lease Obligation: 404000000.00
EMR balance_sheet (annual, 2023-09-30) — Long Term Debt: 7610000000.00
EMR balance_sheet (annual, 2023-09-30) — Long Term Debt And Capital Lease Obligation: 8014000000.00
EMR cash_flow (annual, 2023-09-30) — Long Term Debt Issuance: 0.00
EMR cash_flow (annual, 2023-09-30) — Long Term Debt Payments: -1659000000.00
EMR balance_sheet (annual, 2023-09-30) — Long Term Equity Investment: 3255000000.00
EMR balance_sheet (annual, 2023-09-30) — Machinery Furniture Equipment: 3228000000.00
EMR balance_sheet (annual, 2023-09-30) — Minority Interest: 5909000000.00
EMR income_statement (annual, 2023-09-30) — Minority Interests: 19000000.00
EMR cash_flow (annual, 2023-09-30) — Net Business Purchase And Sale: -529000000.00
EMR cash_flow (annual, 2023-09-30) — Net Common Stock Issuance: -2214000000.00
EMR balance_sheet (annual, 2023-09-30) — Net Debt: 106000000.00
EMR income_statement (annual, 2023-09-30) — Net Income: 13219000000.00
EMR income_statement (annual, 2023-09-30) — Net Income Common Stockholders: 13219000000.00
EMR income_statement (annual, 2023-09-30) — Net Income Continuous Operations: 2261000000.00
EMR income_statement (annual, 2023-09-30) — Net Income Discontinuous Operations: 10939000000.00
EMR income_statement (annual, 2023-09-30) — Net Income From Continuing And Discontinued Operation: 13219000000.00
EMR income_statement (annual, 2023-09-30) — Net Income From Continuing Operation Net Minority Interest: 2280000000.00
EMR cash_flow (annual, 2023-09-30) — Net Income From Continuing Operations: 2261000000.00
EMR income_statement (annual, 2023-09-30) — Net Income Including Noncontrolling Interests: 13200000000.00
EMR income_statement (annual, 2023-09-30) — Net Interest Income: 7000000.00
EMR cash_flow (annual, 2023-09-30) — Net Investment Purchase And Sale: 176000000.00
EMR cash_flow (annual, 2023-09-30) — Net Issuance Payments Of Debt: -3242000000.00
EMR cash_flow (annual, 2023-09-30) — Net Long Term Debt Issuance: -1659000000.00
EMR income_statement (annual, 2023-09-30) — Net Non Operating Interest Income Expense: 7000000.00
EMR cash_flow (annual, 2023-09-30) — Net Other Financing Charges: -169000000.00
EMR cash_flow (annual, 2023-09-30) — Net Other Investing Changes: 777000000.00
EMR balance_sheet (annual, 2023-09-30) — Net PPE: 2363000000.00
EMR cash_flow (annual, 2023-09-30) — Net Short Term Debt Issuance: -1583000000.00
EMR balance_sheet (annual, 2023-09-30) — Net Tangible Assets: -54000000.00
EMR balance_sheet (annual, 2023-09-30) — Non Current Deferred Liabilities: 1969000000.00
EMR balance_sheet (annual, 2023-09-30) — Non Current Deferred Taxes Liabilities: 1969000000.00
EMR balance_sheet (annual, 2023-09-30) — Non Current Note Receivables: 3255000000.00
EMR balance_sheet (annual, 2023-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 435000000.00
EMR income_statement (annual, 2023-09-30) — Normalized EBITDA: 4384000000.00
EMR income_statement (annual, 2023-09-30) — Normalized Income: 2411651000.00
EMR cash_flow (annual, 2023-09-30) — Operating Cash Flow: 637000000.00
EMR cash_flow (annual, 2023-09-30) — Operating Gains Losses: -275000000.00
EMR income_statement (annual, 2023-09-30) — Operating Income: 2759000000.00
EMR income_statement (annual, 2023-09-30) — Operating Revenue: 15165000000.00
EMR balance_sheet (annual, 2023-09-30) — Ordinary Shares Number: 572000000.00
EMR balance_sheet (annual, 2023-09-30) — Other Current Assets: 1244000000.00
EMR balance_sheet (annual, 2023-09-30) — Other Current Borrowings: 546000000.00
EMR balance_sheet (annual, 2023-09-30) — Other Equity Adjustments: -1253000000.00
EMR income_statement (annual, 2023-09-30) — Other Gand A: 4186000000.00
EMR income_statement (annual, 2023-09-30) — Other Income Expense: 137000000.00
EMR balance_sheet (annual, 2023-09-30) — Other Intangible Assets: 6263000000.00
EMR cash_flow (annual, 2023-09-30) — Other Non Cash Items: -429000000.00
EMR balance_sheet (annual, 2023-09-30) — Other Non Current Assets: 2566000000.00
EMR balance_sheet (annual, 2023-09-30) — Other Non Current Liabilities: 698000000.00
EMR income_statement (annual, 2023-09-30) — Other Non Operating Income Expenses: 145000000.00
EMR balance_sheet (annual, 2023-09-30) — Payables: 1275000000.00
EMR balance_sheet (annual, 2023-09-30) — Payables And Accrued Expenses: 4485000000.00
EMR cash_flow (annual, 2023-09-30) — Pension And Employee Benefit Expense: -114000000.00
EMR income_statement (annual, 2023-09-30) — Pretax Income: 2903000000.00
EMR balance_sheet (annual, 2023-09-30) — Properties: 0.00
EMR cash_flow (annual, 2023-09-30) — Purchase Of Business: -705000000.00
EMR balance_sheet (annual, 2023-09-30) — Raw Materials: 1560000000.00
EMR balance_sheet (annual, 2023-09-30) — Receivables: 2518000000.00
EMR income_statement (annual, 2023-09-30) — Reconciled Cost Of Revenue: 7169000000.00
EMR income_statement (annual, 2023-09-30) — Reconciled Depreciation: 1051000000.00
EMR cash_flow (annual, 2023-09-30) — Repayment Of Debt: -3637000000.00
EMR cash_flow (annual, 2023-09-30) — Repurchase Of Capital Stock: -2214000000.00
EMR income_statement (annual, 2023-09-30) — Restructuring And Mergern Acquisition: 141000000.00
EMR balance_sheet (annual, 2023-09-30) — Retained Earnings: 40070000000.00
EMR cash_flow (annual, 2023-09-30) — Sale Of Business: 176000000.00
EMR cash_flow (annual, 2023-09-30) — Sale Of Investment: 176000000.00
EMR income_statement (annual, 2023-09-30) — Selling General And Administration: 4186000000.00
EMR balance_sheet (annual, 2023-09-30) — Share Issued: 953400000.00
EMR cash_flow (annual, 2023-09-30) — Short Term Debt Issuance: 395000000.00
EMR cash_flow (annual, 2023-09-30) — Short Term Debt Payments: -1978000000.00
EMR income_statement (annual, 2023-09-30) — Special Income Charges: -188000000.00
EMR cash_flow (annual, 2023-09-30) — Stock Based Compensation: 250000000.00
EMR balance_sheet (annual, 2023-09-30) — Stockholders Equity: 20689000000.00
EMR balance_sheet (annual, 2023-09-30) — Tangible Book Value: -54000000.00
EMR income_statement (annual, 2023-09-30) — Tax Effect Of Unusual Items: -37349000.00
EMR income_statement (annual, 2023-09-30) — Tax Provision: 642000000.00
EMR income_statement (annual, 2023-09-30) — Tax Rate For Calcs: 0.22
EMR balance_sheet (annual, 2023-09-30) — Total Assets: 42746000000.00
EMR balance_sheet (annual, 2023-09-30) — Total Capitalization: 28299000000.00
EMR balance_sheet (annual, 2023-09-30) — Total Debt: 8561000000.00
EMR balance_sheet (annual, 2023-09-30) — Total Equity Gross Minority Interest: 26598000000.00
EMR income_statement (annual, 2023-09-30) — Total Expenses: 12406000000.00
EMR balance_sheet (annual, 2023-09-30) — Total Liabilities Net Minority Interest: 16148000000.00
EMR balance_sheet (annual, 2023-09-30) — Total Non Current Assets: 28927000000.00
EMR balance_sheet (annual, 2023-09-30) — Total Non Current Liabilities Net Minority Interest: 11116000000.00
EMR income_statement (annual, 2023-09-30) — Total Unusual Items: -169000000.00
EMR income_statement (annual, 2023-09-30) — Total Unusual Items Excluding Goodwill: -169000000.00
EMR balance_sheet (annual, 2023-09-30) — Treasury Shares Number: 381400000.00
EMR balance_sheet (annual, 2023-09-30) — Treasury Stock: 18667000000.00
EMR balance_sheet (annual, 2023-09-30) — Working Capital: 8787000000.00
EMR income_statement (annual, 2024-09-30) — +Operating Expense: 6219000000.00
EMR income_statement (annual, 2024-09-30) — +Total Revenue: 17492000000.00
EMR balance_sheet (annual, 2024-09-30) — Accounts Payable: 1335000000.00
EMR balance_sheet (annual, 2024-09-30) — Accounts Receivable: 2927000000.00
EMR balance_sheet (annual, 2024-09-30) — Accumulated Depreciation: -3378000000.00
EMR balance_sheet (annual, 2024-09-30) — Additional Paid In Capital: 169000000.00
EMR balance_sheet (annual, 2024-09-30) — Allowance For Doubtful Accounts Receivable: -121000000.00
EMR income_statement (annual, 2024-09-30) — Amortization: 1077000000.00
EMR cash_flow (annual, 2024-09-30) — Amortization Cash Flow: 1366000000.00
EMR cash_flow (annual, 2024-09-30) — Amortization Of Intangibles: 1366000000.00
EMR income_statement (annual, 2024-09-30) — Amortization Of Intangibles Income Statement: 1077000000.00
EMR cash_flow (annual, 2024-09-30) — Asset Impairment Charge: 231000000.00
EMR income_statement (annual, 2024-09-30) — Basic Average Shares: 570200000.00
EMR income_statement (annual, 2024-09-30) — Basic EPS: 3.45
EMR cash_flow (annual, 2024-09-30) — Beginning Cash Position: 8051000000.00
EMR balance_sheet (annual, 2024-09-30) — Buildings And Improvements: 2048000000.00
EMR balance_sheet (quarterly, 2024-09-30) — Buildings And Improvements: 2048000000.00
EMR cash_flow (annual, 2024-09-30) — Capital Expenditure: -419000000.00
EMR cash_flow (annual, 2024-09-30) — Capital Expenditure Reported: -419000000.00
EMR balance_sheet (annual, 2024-09-30) — Capital Lease Obligations: 669000000.00
EMR balance_sheet (annual, 2024-09-30) — Capital Stock: 477000000.00
EMR balance_sheet (annual, 2024-09-30) — Cash And Cash Equivalents: 3588000000.00
EMR balance_sheet (annual, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 3588000000.00
EMR cash_flow (annual, 2024-09-30) — Cash Dividends Paid: -1201000000.00
EMR cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Financing Activities: -2455000000.00
EMR cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Investing Activities: -8796000000.00
EMR cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Operating Activities: 3317000000.00
EMR cash_flow (annual, 2024-09-30) — Cash From Discontinued Investing Activities: 3436000000.00
EMR cash_flow (quarterly, 2024-09-30) — Cash From Discontinued Investing Activities: 3400000000.00
EMR cash_flow (annual, 2024-09-30) — Cash From Discontinued Operating Activities: 15000000.00
EMR cash_flow (quarterly, 2024-09-30) — Cash From Discontinued Operating Activities: 11000000.00
EMR cash_flow (annual, 2024-09-30) — Change In Account Payable: -16000000.00
EMR cash_flow (annual, 2024-09-30) — Change In Accrued Expense: -9000000.00
EMR cash_flow (annual, 2024-09-30) — Change In Inventory: 122000000.00
EMR cash_flow (annual, 2024-09-30) — Change In Other Current Assets: -149000000.00
EMR cash_flow (annual, 2024-09-30) — Change In Payable: -16000000.00
EMR cash_flow (annual, 2024-09-30) — Change In Payables And Accrued Expense: -25000000.00
EMR cash_flow (annual, 2024-09-30) — Change In Receivables: -99000000.00
EMR cash_flow (annual, 2024-09-30) — Change In Working Capital: -151000000.00
EMR cash_flow (annual, 2024-09-30) — Changes In Cash: -4483000000.00
EMR balance_sheet (annual, 2024-09-30) — Common Stock: 477000000.00
EMR cash_flow (annual, 2024-09-30) — Common Stock Dividend Paid: -1201000000.00
EMR balance_sheet (annual, 2024-09-30) — Common Stock Equity: 21636000000.00
EMR cash_flow (annual, 2024-09-30) — Common Stock Payments: -643000000.00
EMR balance_sheet (annual, 2024-09-30) — Construction In Progress: 321000000.00
EMR balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 321000000.00
EMR income_statement (annual, 2024-09-30) — Cost Of Revenue: 8607000000.00
EMR balance_sheet (annual, 2024-09-30) — Current Accrued Expenses: 1299000000.00
EMR balance_sheet (annual, 2024-09-30) — Current Assets: 10192000000.00
EMR balance_sheet (annual, 2024-09-30) — Current Capital Lease Obligation: 158000000.00
EMR balance_sheet (annual, 2024-09-30) — Current Debt: 532000000.00
EMR balance_sheet (annual, 2024-09-30) — Current Debt And Capital Lease Obligation: 690000000.00
EMR balance_sheet (annual, 2024-09-30) — Current Deferred Liabilities: 1043000000.00
EMR balance_sheet (annual, 2024-09-30) — Current Deferred Revenue: 1043000000.00
EMR balance_sheet (annual, 2024-09-30) — Current Liabilities: 5742000000.00
EMR balance_sheet (annual, 2024-09-30) — Current Provisions: 82000000.00
EMR balance_sheet (annual, 2024-09-30) — Defined Pension Benefit: 1194000000.00
EMR balance_sheet (quarterly, 2024-09-30) — Defined Pension Benefit: 1194000000.00
EMR cash_flow (annual, 2024-09-30) — Depreciation: 323000000.00
EMR cash_flow (annual, 2024-09-30) — Depreciation Amortization Depletion: 1689000000.00
EMR income_statement (annual, 2024-09-30) — Depreciation Amortization Depletion Income Statement: 1077000000.00
EMR cash_flow (annual, 2024-09-30) — Depreciation And Amortization: 1689000000.00
EMR income_statement (annual, 2024-09-30) — Depreciation And Amortization In Income Statement: 1077000000.00
EMR income_statement (annual, 2024-09-30) — Diluted Average Shares: 574000000.00
EMR income_statement (annual, 2024-09-30) — Diluted EPS: 3.43
EMR income_statement (annual, 2024-09-30) — Diluted NI Availto Com Stockholders: 1968000000.00
EMR income_statement (annual, 2024-09-30) — EBIT: 2343000000.00
EMR income_statement (annual, 2024-09-30) — EBITDA: 4032000000.00
EMR income_statement (annual, 2024-09-30) — Earnings From Equity Interest: 79000000.00
EMR income_statement (quarterly, 2024-09-30) — Earnings From Equity Interest: 0.00
EMR cash_flow (annual, 2024-09-30) — Effect Of Exchange Rate Changes: 20000000.00
EMR balance_sheet (annual, 2024-09-30) — Employee Benefits: 466000000.00
EMR cash_flow (annual, 2024-09-30) — End Cash Position: 3588000000.00
EMR cash_flow (annual, 2024-09-30) — Financing Cash Flow: -2455000000.00
EMR balance_sheet (annual, 2024-09-30) — Finished Goods: 512000000.00
EMR cash_flow (annual, 2024-09-30) — Free Cash Flow: 2913000000.00
EMR cash_flow (annual, 2024-09-30) — Gain Loss On Investment Securities: 200000000.00
EMR cash_flow (quarterly, 2024-09-30) — Gain Loss On Investment Securities: -79000000.00
EMR income_statement (annual, 2024-09-30) — Gain On Sale Of Business: 0.00
EMR income_statement (quarterly, 2024-09-30) — Gain On Sale Of Business: 318000000.00
EMR income_statement (annual, 2024-09-30) — Gain On Sale Of Security: -105000000.00
EMR balance_sheet (annual, 2024-09-30) — Gains Losses Not Affecting Retained Earnings: -868000000.00
EMR income_statement (annual, 2024-09-30) — General And Administrative Expense: 5142000000.00
EMR balance_sheet (annual, 2024-09-30) — Goodwill: 18067000000.00
EMR balance_sheet (annual, 2024-09-30) — Goodwill And Other Intangible Assets: 28503000000.00
EMR balance_sheet (annual, 2024-09-30) — Gross Accounts Receivable: 3048000000.00
EMR balance_sheet (annual, 2024-09-30) — Gross PPE: 6877000000.00
EMR income_statement (annual, 2024-09-30) — Gross Profit: 8885000000.00
EMR balance_sheet (annual, 2024-09-30) — Income Tax Payable: 587000000.00
EMR balance_sheet (quarterly, 2024-09-30) — Income Tax Payable: 587000000.00
EMR income_statement (annual, 2024-09-30) — Interest Expense: 323000000.00
EMR income_statement (annual, 2024-09-30) — Interest Expense Non Operating: 323000000.00
EMR income_statement (annual, 2024-09-30) — Interest Income: 234000000.00
EMR income_statement (annual, 2024-09-30) — Interest Income Non Operating: 234000000.00
EMR balance_sheet (annual, 2024-09-30) — Inventory: 2180000000.00
EMR balance_sheet (annual, 2024-09-30) — Invested Capital: 29323000000.00
EMR cash_flow (annual, 2024-09-30) — Investing Cash Flow: -5360000000.00
EMR balance_sheet (annual, 2024-09-30) — Investments And Advances: 0.00
EMR balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 0.00
EMR cash_flow (annual, 2024-09-30) — Issuance Of Debt: 322000000.00
EMR balance_sheet (annual, 2024-09-30) — Land And Improvements: 278000000.00
EMR balance_sheet (quarterly, 2024-09-30) — Land And Improvements: 278000000.00
EMR balance_sheet (annual, 2024-09-30) — Long Term Capital Lease Obligation: 511000000.00
EMR balance_sheet (annual, 2024-09-30) — Long Term Debt: 7155000000.00
EMR balance_sheet (annual, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 7666000000.00
EMR cash_flow (annual, 2024-09-30) — Long Term Debt Issuance: 0.00
EMR cash_flow (annual, 2024-09-30) — Long Term Debt Payments: -547000000.00
EMR balance_sheet (annual, 2024-09-30) — Long Term Equity Investment: 0.00
EMR balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 0.00
EMR balance_sheet (annual, 2024-09-30) — Machinery Furniture Equipment: 3538000000.00
EMR balance_sheet (quarterly, 2024-09-30) — Machinery Furniture Equipment: 3538000000.00
EMR balance_sheet (annual, 2024-09-30) — Minority Interest: 5873000000.00
EMR income_statement (annual, 2024-09-30) — Minority Interests: 13000000.00
EMR cash_flow (annual, 2024-09-30) — Net Business Purchase And Sale: -8263000000.00
EMR cash_flow (annual, 2024-09-30) — Net Common Stock Issuance: -643000000.00
EMR balance_sheet (annual, 2024-09-30) — Net Debt: 4099000000.00
EMR income_statement (annual, 2024-09-30) — Net Income: 1968000000.00
EMR income_statement (annual, 2024-09-30) — Net Income Common Stockholders: 1968000000.00
EMR income_statement (annual, 2024-09-30) — Net Income Continuous Operations: 1605000000.00
EMR income_statement (annual, 2024-09-30) — Net Income Discontinuous Operations: 350000000.00
EMR income_statement (quarterly, 2024-09-30) — Net Income Discontinuous Operations: 438000000.00
EMR income_statement (annual, 2024-09-30) — Net Income From Continuing And Discontinued Operation: 1968000000.00
EMR income_statement (annual, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: 1618000000.00
EMR cash_flow (annual, 2024-09-30) — Net Income From Continuing Operations: 1605000000.00
EMR income_statement (annual, 2024-09-30) — Net Income Including Noncontrolling Interests: 1955000000.00
EMR income_statement (annual, 2024-09-30) — Net Interest Income: -89000000.00
EMR cash_flow (annual, 2024-09-30) — Net Investment Purchase And Sale: 79000000.00
EMR cash_flow (annual, 2024-09-30) — Net Issuance Payments Of Debt: -567000000.00
EMR cash_flow (annual, 2024-09-30) — Net Long Term Debt Issuance: -547000000.00
EMR income_statement (annual, 2024-09-30) — Net Non Operating Interest Income Expense: -89000000.00
EMR cash_flow (annual, 2024-09-30) — Net Other Financing Charges: -44000000.00
EMR cash_flow (annual, 2024-09-30) — Net Other Investing Changes: -114000000.00
EMR balance_sheet (annual, 2024-09-30) — Net PPE: 3499000000.00
EMR cash_flow (annual, 2024-09-30) — Net Short Term Debt Issuance: -20000000.00
EMR balance_sheet (annual, 2024-09-30) — Net Tangible Assets: -6867000000.00
EMR balance_sheet (annual, 2024-09-30) — Non Current Accounts Receivable: 556000000.00
EMR balance_sheet (quarterly, 2024-09-30) — Non Current Accounts Receivable: 556000000.00
EMR balance_sheet (annual, 2024-09-30) — Non Current Deferred Assets: 64000000.00
EMR balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Assets: 64000000.00
EMR balance_sheet (annual, 2024-09-30) — Non Current Deferred Liabilities: 2138000000.00
EMR balance_sheet (annual, 2024-09-30) — Non Current Deferred Taxes Assets: 64000000.00
EMR balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 64000000.00
EMR balance_sheet (annual, 2024-09-30) — Non Current Deferred Taxes Liabilities: 2138000000.00
EMR balance_sheet (annual, 2024-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 466000000.00
EMR income_statement (annual, 2024-09-30) — Normalized EBITDA: 4461000000.00
EMR income_statement (annual, 2024-09-30) — Normalized Income: 1958626000.00
EMR cash_flow (annual, 2024-09-30) — Operating Cash Flow: 3332000000.00
EMR cash_flow (annual, 2024-09-30) — Operating Gains Losses: 83000000.00
EMR cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: -117000000.00
EMR income_statement (annual, 2024-09-30) — Operating Income: 2666000000.00
EMR income_statement (annual, 2024-09-30) — Operating Revenue: 17492000000.00
EMR balance_sheet (annual, 2024-09-30) — Ordinary Shares Number: 570200000.00
EMR balance_sheet (annual, 2024-09-30) — Other Current Assets: 1497000000.00
EMR balance_sheet (annual, 2024-09-30) — Other Current Borrowings: 532000000.00
EMR balance_sheet (annual, 2024-09-30) — Other Equity Adjustments: -868000000.00
EMR income_statement (annual, 2024-09-30) — Other Gand A: 5142000000.00
EMR income_statement (annual, 2024-09-30) — Other Income Expense: -557000000.00
EMR balance_sheet (annual, 2024-09-30) — Other Intangible Assets: 10436000000.00
EMR cash_flow (annual, 2024-09-30) — Other Non Cash Items: -169000000.00
EMR balance_sheet (annual, 2024-09-30) — Other Non Current Assets: 238000000.00
EMR balance_sheet (annual, 2024-09-30) — Other Non Current Liabilities: 725000000.00
EMR income_statement (annual, 2024-09-30) — Other Non Operating Income Expenses: -207000000.00
EMR balance_sheet (annual, 2024-09-30) — Other Properties: 692000000.00
EMR balance_sheet (quarterly, 2024-09-30) — Other Properties: 692000000.00
EMR balance_sheet (annual, 2024-09-30) — Payables: 1922000000.00
EMR balance_sheet (annual, 2024-09-30) — Payables And Accrued Expenses: 3221000000.00
EMR cash_flow (annual, 2024-09-30) — Pension And Employee Benefit Expense: -117000000.00
EMR balance_sheet (annual, 2024-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 706000000.00
EMR income_statement (annual, 2024-09-30) — Pretax Income: 2020000000.00
EMR balance_sheet (annual, 2024-09-30) — Properties: 0.00
EMR balance_sheet (quarterly, 2024-09-30) — Properties: 0.00
EMR cash_flow (annual, 2024-09-30) — Purchase Of Business: -8342000000.00
EMR balance_sheet (annual, 2024-09-30) — Raw Materials: 1668000000.00
EMR balance_sheet (annual, 2024-09-30) — Receivables: 2927000000.00
EMR income_statement (annual, 2024-09-30) — Reconciled Cost Of Revenue: 7995000000.00
EMR income_statement (annual, 2024-09-30) — Reconciled Depreciation: 1689000000.00
EMR cash_flow (annual, 2024-09-30) — Repayment Of Debt: -889000000.00
EMR cash_flow (annual, 2024-09-30) — Repurchase Of Capital Stock: -643000000.00
EMR income_statement (annual, 2024-09-30) — Restructuring And Mergern Acquisition: 324000000.00
EMR balance_sheet (annual, 2024-09-30) — Retained Earnings: 40830000000.00
EMR cash_flow (annual, 2024-09-30) — Sale Of Business: 79000000.00
EMR cash_flow (quarterly, 2024-09-30) — Sale Of Business: -79000000.00
EMR cash_flow (annual, 2024-09-30) — Sale Of Investment: 79000000.00
EMR income_statement (annual, 2024-09-30) — Selling General And Administration: 5142000000.00
EMR balance_sheet (annual, 2024-09-30) — Share Issued: 953400000.00
EMR cash_flow (annual, 2024-09-30) — Short Term Debt Issuance: 322000000.00
EMR cash_flow (annual, 2024-09-30) — Short Term Debt Payments: -342000000.00
EMR income_statement (annual, 2024-09-30) — Special Income Charges: -324000000.00
EMR cash_flow (annual, 2024-09-30) — Stock Based Compensation: 260000000.00
EMR balance_sheet (annual, 2024-09-30) — Stockholders Equity: 21636000000.00
EMR balance_sheet (annual, 2024-09-30) — Tangible Book Value: -6867000000.00
EMR income_statement (annual, 2024-09-30) — Tax Effect Of Unusual Items: -88374000.00
EMR income_statement (annual, 2024-09-30) — Tax Provision: 415000000.00
EMR income_statement (annual, 2024-09-30) — Tax Rate For Calcs: 0.21
EMR balance_sheet (annual, 2024-09-30) — Total Assets: 44246000000.00
EMR balance_sheet (annual, 2024-09-30) — Total Capitalization: 28791000000.00
EMR balance_sheet (annual, 2024-09-30) — Total Debt: 8356000000.00
EMR balance_sheet (annual, 2024-09-30) — Total Equity Gross Minority Interest: 27509000000.00
EMR income_statement (annual, 2024-09-30) — Total Expenses: 14826000000.00
EMR balance_sheet (annual, 2024-09-30) — Total Liabilities Net Minority Interest: 16737000000.00
EMR balance_sheet (annual, 2024-09-30) — Total Non Current Assets: 34054000000.00
EMR balance_sheet (annual, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 10995000000.00
EMR balance_sheet (annual, 2024-09-30) — Total Tax Payable: 587000000.00
EMR balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 587000000.00
EMR income_statement (annual, 2024-09-30) — Total Unusual Items: -429000000.00
EMR income_statement (annual, 2024-09-30) — Total Unusual Items Excluding Goodwill: -429000000.00
EMR balance_sheet (annual, 2024-09-30) — Treasury Shares Number: 383200000.00
EMR balance_sheet (annual, 2024-09-30) — Treasury Stock: 18972000000.00
EMR balance_sheet (annual, 2024-09-30) — Working Capital: 4450000000.00
EMR cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
EMR cash_flow (quarterly, 2024-12-31) — Cash From Discontinued Investing Activities: 0.00
EMR cash_flow (quarterly, 2024-12-31) — Cash From Discontinued Operating Activities: 0.00
EMR cash_flow (quarterly, 2024-12-31) — Common Stock Dividend Paid: -301000000.00
EMR income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: 0.00
EMR income_statement (quarterly, 2025-03-31) — +Operating Expense: 1512000000.00
EMR income_statement (quarterly, 2025-03-31) — +Total Revenue: 4432000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1340000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2901000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -3401000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 0.00
EMR balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -124000000.00
EMR income_statement (quarterly, 2025-03-31) — Amortization: 229000000.00
EMR cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 301000000.00
EMR cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 301000000.00
EMR income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 229000000.00
EMR income_statement (quarterly, 2025-03-31) — Basic Average Shares: 562500000.00
EMR income_statement (quarterly, 2025-03-31) — Basic EPS: 0.86
EMR cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 2834000000.00
EMR cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -87000000.00
EMR cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -87000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 637000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Capital Stock: 477000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1887000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1887000000.00
EMR cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -297000000.00
EMR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -1091000000.00
EMR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -122000000.00
EMR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 826000000.00
EMR cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Investing Activities: 0.00
EMR cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Operating Activities: -585000000.00
EMR cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 18000000.00
EMR cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 182000000.00
EMR cash_flow (quarterly, 2025-03-31) — Change In Inventory: 19000000.00
EMR cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -87000000.00
EMR cash_flow (quarterly, 2025-03-31) — Change In Payable: 18000000.00
EMR cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 200000000.00
EMR cash_flow (quarterly, 2025-03-31) — Change In Receivables: -181000000.00
EMR cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -49000000.00
EMR cash_flow (quarterly, 2025-03-31) — Changes In Cash: -972000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Common Stock: 477000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 19249000000.00
EMR cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -223000000.00
EMR income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2061000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 1263000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Current Assets: 8627000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 149000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Current Debt: 6038000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 6187000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 1112000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 1112000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 10846000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Current Provisions: 84000000.00
EMR cash_flow (quarterly, 2025-03-31) — Depreciation: 83000000.00
EMR cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 384000000.00
EMR income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 229000000.00
EMR cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 384000000.00
EMR income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 229000000.00
EMR income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 565400000.00
EMR income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.86
EMR income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 485000000.00
EMR income_statement (quarterly, 2025-03-31) — EBIT: 715000000.00